Inicio › Cáncer metastásico › Nueva Jersey

Ensayos clínicos de Cáncer metastásico en Nueva Jersey

44 estudios sobre Cáncer metastásico buscan participantes en Nueva Jersey.

Ciudades en Nueva Jersey

Texto oficial del estudio (inglés)

A Study of ASP3082 in Adults With Advanced Solid Tumors

Hackensack University Medical Center, Hackensack

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT05382559

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

ALX Center 12, Morristown

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07085091

First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors

Astera Cancer Care, East Brunswick

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT05875168

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Hunterdon Medical Center, Flemington
Monmouth Medical Center Southern Campus, Lakewood
Cooperman Barnabas Medical Center, Livingston
y 6 más

ReclutandoFase 2

Todas las edades · Todos los sexos · Actualizado el 29 sept 2026 · NCT05564377

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

START Astera, LLC, East Brunswick

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07277413

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

John Theurer Cancer Center at Hackensack UMC, Hackensack

ReclutandoFase 1

Edades de 19 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06586957

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Atlantic Health System / Morristown Medical Center, Morristown
Jack & Sheryl Morris Cancer Center, New Brunswick
Rutgers Cancer Institute, New Brunswick
y 3 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06989437

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Regional Cancer Care, Belleville

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07562152

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

John Theurer Cancer Center, Hackensack

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 24 sept 2026 · NCT07543055

A Study of ZEN003694 in People With Squamous Cell Lung Cancer

Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT05607108

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Astera Cancer Care, East Brunswick

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07218380

SLV-154 Treatment of Advanced Cancers

Astera Cancer Care, East Brunswick

ReclutandoFase 1

Edades de 12 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06771219

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Jefferson Health - Cherry Hill, Cherry Hill
Sidney Kimmel Cancer Center - Washington Township, Sewell
Atlantic Health System Overlook Medical Center, Summit

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07174336

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Morristown Medical Center, Morristown

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07262619

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Hackensack University Medical Center, Hackensack

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07629960

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

MSK Basking Ridge, Basking Ridge
MSK Monmouth, Middletown
MSK Bergen, Montvale

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07227415

A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0105), Hackensack

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT07030712

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

The Valley Hospital, Inc., Paramus

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06119581

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Hunterdon Medical Center, Flemington

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06072612

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT05837767

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Atlantic Health, Morristown
Rutgers Cancer Institute of New Jersey, New Brunswick

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT04913285

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Research Site, Trenton

ReclutandoFase 2

Edades de 18 a 130 · Todos los sexos · Actualizado el 18 ago 2026 · NCT06792695

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 ago 2026 · NCT05859074

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

START New Jersey, East Brunswick

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT06270706

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Research Site, Camden
Research Site, Paramus

ReclutandoFase 3

Edades de 18 en adelante · Mujeres · Actualizado el 29 jul 2026 · NCT07044336

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

John Theurer Cancer Center, Hackensack

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 14 jul 2026 · NCT05533697

A Study of LY4175408 in Participants With Advanced Cancer

John Theurer Cancer Center At Hackensack UMC, Hackensack

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jun 2026 · NCT07046923

FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jun 2026 · NCT07638371

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Rutgers Cancer Institute, New Brunswick
RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT05686226

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Context Investigational Site, Hackensack

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT06756035

Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer

The Valley Hospital-Luckow Pavilion, Paramus

ReclutandoFase 1

Edades de 18 a 99 · Todos los sexos · Actualizado el 5 jun 2026 · NCT05232409

Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas

RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton
RWJBarnabas Health - Monmouth Medical Center Southern Campus, Lakewood
RWJBarnabas Health - Saint Barnabas Medical Center, Livingston
y 4 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 jun 2026 · NCT05419518

Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Jefferson Health New Jersey, Sewell

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 may 2026 · NCT03184038

Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma

Hackensack University Medical Center, Hackensack

ReclutandoFase 2

Edades de 8 a 30 · Todos los sexos · Actualizado el 22 may 2026 · NCT05726383

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Hackensack University Medical Center, Hackensack

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 may 2026 · NCT07094204

A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
Memorial Sloan Kettering Bergen (All protocol activities), Montvale

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 may 2026 · NCT05010031

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 abr 2026 · NCT05562791

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Hackensack University Medical Center, Hackensack
Atlantic Health System, Morristown

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 abr 2026 · NCT06947928

A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale

ReclutandoFase 2

Edades de 6 a 49 · Todos los sexos · Actualizado el 17 mar 2026 · NCT07477457

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

Atlantic Health, Summit

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 feb 2026 · NCT07049055

De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.